When bankers were trying to do a share offering a few years back for a fledgling cannabis company, it was tough to get investors to take meetings. The ones that did often couldn’t get comfortable with the sector.

“It was a hard sell,” said Steve Ottaway, head of health-care investment banking at GMP Capital Inc., which led the deal. “People were very skeptical.”

Now,...